Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Director/PDMR Shareholding

4 Jun 2018 15:14

RNS Number : 2355Q
FDM Group (Holdings) plc
04 June 2018
 

4 June 2018

FDM Group (Holdings) plc

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

PSP Award - 1 June 2018

On 1 June 2018 FDM Group (Holdings) plc ("FDM") granted awards over ordinary shares in the Company under the FDM 2014 Performance Share Plan (the "PSP"), as noted below.

The vesting of the awards is subject to the achievement of a performance condition based upon the annual compound growth in FDM's earnings per share over the three-year performance period commencing with FDM's 2018 financial year. Ordinarily, the awards and options will vest (subject to the achievement of the performance condition) following the announcement of FDM's results for its 2020 financial year.

Other than in the case of Jonathan Young, the awards have been structured as "Approved PSP" ("APSP") awards to take account of potential tax advantages for the participants and FDM. Each APSP award consists of a tax qualifying option under the FDM Company Share Option Plan (the "CSOP") over shares with a value of up to £30,000 and with an exercise price of £10.21 per share, a "Linked Award" under the PSP which is principally a funding award to fund the exercise price of the CSOP option and a separate award under the PSP in respect of the balance of the value of the award above £30,000, as noted below.

Jonathan Young is not eligible to receive an award under the CSOP and, accordingly, has received only an award under the PSP

Each award (including the Linked Awards) under the PSP has been granted in the form of an option with an exercise price per share of £0.01

Name

Number of shares subject to PSP award

Number of shares subject to CSOP option

Maximum number of shares subject to Linked Award*

Executive Directors

Rod Flavell

15,562

2,938

2,938

Sheila Flavell

15,562

2,938

2,938

Andy Brown

15,562

2,938

2,938

Mike McLaren

15,562

2,938

2,938

Other Senior Managers

Jonathan Young

18,500

N/A

N/A

Stewart Sharman

4,312

2,938

2,938

 

*Each Linked Award is principally to fund the exercise price of the CSOP option. If the CSOP option is exercised at a gain, the Linked Award will be exercisable over such number of shares as have a market value at the date of exercise equal to the aggregate exercise price of the CSOP option. If the CSOP option is not capable of exercise at a gain and is released, the Linked Award may be exercised in respect of the number of shares in respect of which it vests.

 

The notification below, made pursuant to Article 19 of Regulation (EU) No 596/2014 on Market Abuse, provides further information about these transactions.

1

Details of the person discharging managerial responsibilities / person closely associated

 

(a)

Name

(i) Rod Flavell

(ii) Sheila Flavell

(iii) Andy Brown

(iv) Mike McLaren

(v) Jonathan Young

(vi) Stewart Sharman

 

2

Reason for the notification

 

(a)

Position/Status

(i) Chief Executive Officer

(ii) Chief Operating Officer

(iii) Chief Commercial Officer

(iv) Chief Financial Officer

(v) Chief Information Officer

(vi) Senior Manager

 

(b)

Initial notification / Amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

FDM Group (Holdings) Plc

 

(b)

LEI

213800YR62D7GUZLMZ71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of £0.01

 

 

ISIN: GB00BLWDVP51

(b)

Nature of the transaction

 

Grant of awards over ordinary shares

 

(c)

Price(s) and volume(s)

 

Name

Price

Number of ordinary shares subject to PSP award

Number of ordinary shares subject to CSOP option

Maximum number of ordinary shares subject to Linked Award

Rod Flavell

Nil

15,562

2,938

2,938

Sheila Flavell

Nil

15,562

2,938

2,938

Andy Brown

Nil

15,562

2,938

2,938

Mike McLaren

Nil

15,562

2,938

2,938

Jonathan Young

Nil

18,500

N/A

N/A

Stewart Sharman

Nil

4,312

2,938

2,938

 

(d)

Aggregated Information

- Aggregated Volume

 

 

 

 

 

 

 

 

 

 

 

 

- Price

 

Name

Number of ordinary shares subject to awards in total

Rod Flavell

21,438

Sheila Flavell

21,438

Andy Brown

21,438

Mike McLaren

21,438

Jonathan Young

18,500

Stewart Sharman

10,188

 

 

 

N/A

(e)

Date of the Transaction

1 June 2018

 

(f)

Place of the Transaction

Outside a trading venue

 

Name of authorised official of issuer responsible for making notification:

Mark Heather, Company Secretary, FDM Group (Holdings) Plc

 

Enquiries:

FDM

Mike McLaren - Chief Financial Officer

0203 056 8240

Weber Shandwick

Nick Oborne / Tom Jenkins

020 7067 0000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEALKLEFFPEFF
Date   Source Headline
8th Jun 20268:24 amRNSDisclosure of PSP Performance Condition Targets
3rd Jun 202611:01 amRNSAdmission to Trading
2nd Jun 20262:23 pmRNSDirector Shareholding & Block Listing Application
1st Jun 20267:00 amRNSTotal Voting Rights
21st May 20264:39 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
27th Apr 20263:51 pmRNSNotification of Transactions of Directors & PDMRs
21st Apr 20262:18 pmRNSDirector / PCA Shareholding
20th Apr 20267:00 amRNSDirector / PCA Shareholding
10th Apr 20264:34 pmRNS2026 Notice of Annual General Meeting
20th Mar 20265:18 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPreliminary Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
1st Dec 20259:17 amRNSTotal Voting Rights
13th Nov 202512:35 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
6th Nov 20254:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
17th Oct 20251:03 pmRNSDirector/PDMR Shareholding
4th Sep 20254:31 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202510:55 amRNSDirector/PDMR Shareholding
5th Aug 202510:03 amRNSHolding(s) in Company
1st Aug 20258:50 amRNSTotal Voting Rights
31st Jul 20255:27 pmRNSPDMR Shareholding
31st Jul 20253:45 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHalf-year Report
15th Jul 20255:07 pmRNSHolding(s) in Company
7th Jul 20259:48 amRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirectorate Change
6th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
23rd May 20255:07 pmRNSDirector/PCA Shareholding
20th May 20255:28 pmRNSResult of AGM
20th May 20257:00 amRNSAnnual General Meeting Statement
9th May 202511:10 amRNSDirector/PDMR Shareholding
8th May 20252:55 pmRNSDirector/PDMR Shareholding
1st May 20251:17 pmRNSDirector/PDMR Shareholding
23rd Apr 20259:51 amRNSDirector Shareholding
9th Apr 20254:32 pmRNSDirector/PDMR Shareholding
8th Apr 20255:42 pmRNSNotice of Annual General Meeting
1st Apr 20257:00 amRNSTotal Voting Rights
20th Mar 20254:31 pmRNSDirector / PCR Shareholding
19th Mar 20257:00 amRNSDirectorate Change
19th Mar 20257:00 amRNSPreliminary Announcement of Results FY2024
14th Mar 20254:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.